Related Experiment Video
Updated: Jul 2, 2025
12:24
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.2K
[Research progress on the effect of common metabolism-related comorbidities on health outcomes and management
1Department of Medical Statistics, School of Public Health, Sun Yat-sen University, Guangzhou 510080, China.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi
|February 27, 2024
Summary
Chronic hepatitis B (CHB) patients face increasing risks from non-communicable diseases (NCDs). This study examines how comorbidities like metabolic syndrome and diabetes impact CHB outcomes and management.
Area of Science:
- Hepatology
- Internal Medicine
- Public Health
Context:
- Rising life expectancy and lifestyle shifts in chronic hepatitis B (CHB) patients increase the prevalence of non-communicable diseases (NCDs).
- Comorbidities significantly influence disease progression and prognosis in CHB.
- Metabolism-related diseases, including metabolic syndrome and diabetes, are common in CHB populations.
Purpose:
- To investigate the association between CHB and NCD comorbidities.
- To analyze the impact of common metabolic diseases on CHB patient health outcomes.
- To summarize integrated management strategies and provide recommendations for CHB patients with comorbidities.
Summary:
- This study explores the link between chronic hepatitis B (CHB) and non-communicable diseases (NCDs), focusing on metabolic syndrome and diabetes.
- It examines how these comorbidities affect CHB patient health and reviews current management approaches.
- Findings aim to improve understanding of clinical characteristics and guide comprehensive management.
Impact:
- Provides a foundation for understanding the clinical characteristics and prevalence of NCD comorbidities in CHB.
- Aims to reduce the disease burden associated with comorbidities in CHB patients.
- Supports the establishment of coordinated management systems for CHB patients with co-existing NCDs.
More Related Videos
Related Concept Videos
01:19Factors Affecting Drug Biotransformation: Biological
149
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
149
01:24Overview of Lipid Metabolism
1.5K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.5K
01:29Chronic Pancreatitis II: Collaborative Care
88
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
88
01:30Acute Pancreatitis II: Clinical Manifestations and Management
124
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
124
01:21Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
244
A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
The drug's acidity or basicity is essential in...
The drug's acidity or basicity is essential in...
244
01:17Chronic Bowel Disorders: Introduction
450
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
450